Omda AS provides software solutions for the healthcare and emergency response sector in Norway, Sweden, Denmark, Finland, and internationally. The company offers laboratory information management systems consisting of Omda ProSang, a blood, cell, and tissue management system; and medical medication solution comprising Omda Cytodose, an oncology medication management solution. It also provides connected healthcare solutions, including Omda Cardio, an ECG and diagnostic storage tool; Omda CIMA, a clinical imaging mobile application; Omda Media, a web-based medical imaging solution; Omda Medimaker, an image management and workflow solution; Omda Picsara, an image management solution; Omda Arcidis, an integrated teleradiology system; Omda Helsemail, a patient data transfer tool; Omda Plutus, an audit and workflow monitoring platform; Omda S7, an e-care communications platform; and Omda XDS, a patient data storage and management solution. In addition, the company offers Omda Fertsoft, a data solution for advanced-assisted reproductive technology clinics; Omda iPana Hospital, a digital maternity solution; Omda iPana Maternity, a cloud-based platform for women's maternity care; and Omda Partus, a data solution for the maternity sector, as well as health analytics products comprising Omda Compos, a medical data management solution; and Omda MedSciNet for collection, analysis, and management of medical data. Further, it provides Omda Optima that enables emergency organizations to test resource distribution and operational strategy through digital simulations; Omda CoordCom, an integrated response management and complete reliability platform; Omda AMIS, a digital platform for processing emergency calls and coordinating various aspects of the medical response; and Omda Paratus, an emergency response system. The company was formerly known as CSAM Health Group AS and changed its name to Omda AS in September 2023. Omda AS was founded in 1999 and is headquartered in Oslo, Norway.…
Omda venter høy vekst etter Saab-oppkjøp
Omda (OSL: OMDA) is listed on Oslo Børs, where its shares trade in NOK. It belongs to the Health Information Services industry, part of the Healthcare sector, and reports about 255 employees.
The shares were at 42.50 NOK on 20 November 2026, down 8.5% over 52 weeks. Its 52-week range is 33.00 NOK to 51.40 NOK: the price is 17.3% below the high and 28.8% above the low.
Its market capitalisation is 871.58M NOK. It pays a dividend yielding 1.06%, against a median of 1.44% among the dividend payers in that peer group.
Omda reports return on equity of 39.6%, an operating margin of 10.8% and revenue down 5.3% year over year.
Its debt exceeds its cash by 532.84M NOK. Its Piotroski F-score is 8 out of 9, a strong reading of its financial health. One analyst covers the stock, with an average rating of Strong Buy; their mean price target of 62.00 NOK is 45.9% above the current price.